tbuckley/cabot-search huggingface dataset:
P2.09-38 MRI Radiomics Approach to Predict the Intracranial Efficacy of the Third Generation EGFR-TKI Osimertinib in NSCLC Patients with Brain Metastases
Authors: X. Tang, Y. Li, W.-L. Qian, P.-L. Han, W.-F. Yan, Z.-G. Yang
Journal: Journal of Thoracic Oncology (2023)
EP12.01-15 Aumolertinib Combination SBRT Treated EGFR Co-mutation Patients with Symptomatic Brain Metastases: A Case Report
Authors: X. Zhang, M. Zhang, X. Du, G. Zhang, Y. Niu, C. Wei, L. Guo, C. Shi, H. Wang
Journal: Journal of Thoracic Oncology (2023)
EP01.01-01 Adenocarcinoma and Small Cell Lung Cancer Risk Associated with Occupation in Women
Authors: A. Ruano Ravina, C. Candal-Pedreira, E. Torres, J. Rey-Brandariz, C. Guerra-Tort, L. Varela-Lema, M. Pérez-Ríos
Journal: Journal of Thoracic Oncology (2023)
EP10.01-11 Efficacy of Intraventricular Chemotherapy with Pemetrexed for Leptomeningeal Metastasis from Lung Adenocarcinoma: A Retrospective Study
Authors: S. Fang, T. Xu, N. Liu, X. Wang, W. Cheng, H. Fang
Journal: Journal of Thoracic Oncology (2023)
P1.02-05 METTL3-mediated m6A Modification of SRPK1 Promotes Lung Adenocarcinoma through Aerobic Glycolysis
Authors: A. Wang, Y. Zeng, W. Zhang, J. Zhao, L. Gao, J. Li, J. Zhu, Z. Liu, J-a. Huang
Journal: Journal of Thoracic Oncology (2023)
P2.09-08 Gefitinib Maintenance After Definitive CCRT in EGFR mutant Stage III NSCLC: Single Arm, Open Label, Multicenter Phase 2 Trial
Authors: Y. Jang, C.-M. Choi, I.-J. Oh, Y.-C. Kim, W. Ji, J.C. Lee
Journal: Journal of Thoracic Oncology (2023)
EP07.04-06 ALK Rearrangement Is Associated with Early Lymphatic Spread in Resected LUAD with Negative Preoperative Mediastinal Staging
Authors: F.T. Gallina, R. Tajè, F.L. Cecere, E. Melis, L. Bertolaccini, L. Spaggiari, F. de Marinis, G. Cannone, A. Busetto, F. Rea, N. Martucci, E. Mercadante, N. Normanno, F. Mazzoni, S. Bongiolatti, L. Voltolini, I. Sperduti, F. Cappuzzo, F. Facciolo
Journal: Journal of Thoracic Oncology (2023)
P1.08-05 On-Target Acquired Resistance to Mobocertinib and Strategy to Overcome It - In Vitro Study Using EGFR Ex20 Insertion Models
Authors: A. Hamada, K. Suda, S. Fukuda, M. Nishino, S. Ohara, M. Chiba, M. Shimoji, T. Takemoto, J. Soh, Y. Tsutani, T. Mitsudomi
Journal: Journal of Thoracic Oncology (2023)
P1.28-04 Should Older Patients with Stage Iii Non-small-Cell Lung Cancer Be Treated with Concurrent Chemoradiotherapy?
Authors: N.D. Wallace, M. Alexander, S. Xie, D. Ball, B. Solomon, N. Plumridge, M. Shaw, S. Harden, F. Hegi-Johnson, S. Siva, T. John, A. Officer, M. MacManus
Journal: Journal of Thoracic Oncology (2023)
P1.28-01 Adherence to Post-treatment Surveillance Guidelines in Non-small Cell Lung Cancer - A Veteran’s Health Administration Cohort
Authors: R. Randle, U. Ajawara, S. Adams, S. Han, R. Laundry, S. Zeliadt, J. Wu, A. Leung, A. Sox-Harris, L. Backhus
Journal: Journal of Thoracic Oncology (2023)
P2.01-03 Efficiency and Survival Data of Neoadjuvant PD-1 Inhibitor Combined With Chemotherapy in Potentially Resectable IIIA or IIIB NSCLC
Authors: K. Ma, C. Sun, X. Wang, Y. Xu, Y. Guo, S. Qiu, G. Shao, Z. Yang, P. Zhang, Y. Liu, X. Ma
Journal: Journal of Thoracic Oncology (2023)
P1.18-07 Systematic Enrolment Ensures High Participation Rate in Lung Cancer Screening - Results of Regional Pilot Study in Estonia
Authors: T. Laisaar, K. Kallavus, A. Poola, M. Tõnissoo, M. Taur, V. Makke, M. Frik, P. Ilves, K.-T. Laisaar
Journal: Journal of Thoracic Oncology (2023)
OA21.03 A Phase 3b Study of 1L Savolitinib in Patients with Locally Advanced or Metastatic NSCLC Harboring MET Exon 14 Mutation
Authors: S. Lu, Y. Yu, Q. Guo, Y. Li, D. Zhong, L. Gu, J. Fang, S. Han, P. Pan, P. Deng, B. Liu, M. Wang, H. Wu, F. Gao, W. Lin, J. Li, D. Lv, S. He, Z. Liu, C. Pan, J. Li, Y. Tian, N. Yang, Y. Zhang, C. Liu, X. Zhu, Q. Song, J. Yu, S. Fan, Y. Ren, M. Shi, W. Su
Journal: Journal of Thoracic Oncology (2023)
EP08.01-02 Single-Cell RNA Sequencing Reveals Unique Immune Landscape in Rare-Mutant Non-Small Cell Lung Cancer Undergoing Chemo-Immunotherapy
Authors: R. Fu, C. Zhang, M.-M. Song, X. Gao, X.-F. Xia, M. Cai, F. Li, Y.-L. Wu, W.-Z. Zhong
Journal: Journal of Thoracic Oncology (2023)
EP01.01-10 Long-term Survivals Associated with High Levels of Na+ and Ca2+ in the Blood of Patients with Stage IV Lung Cancer
Authors: W. Xu, Z. Liang, Y. Han, J. Zhang, Y. Zhang, C. Lin, C. Zhao, Z. Ye, L. Yang, F.-M.(. Kong
Journal: Journal of Thoracic Oncology (2023)
P2.09-21 VRN110755, A New Therapeutic Option for EGFR Mutation-Driven NSCLC with Brain Metastasis or 1st-line Osimertinib-Resistant EGFR Mutations
Authors: H.R. Jung, Y. Lee, S.-H. Kim, D.-H. Seo, D. Kim, S. Kim
Journal: Journal of Thoracic Oncology (2023)
EP08.04-04 Development of a Risk Score to Predict Postoperative Complications in Patients with Non-small Cell Lung Cancer
Authors: M. Mallaev, N. Tsvetkov, U. Simmen, H. Bachmann, D. Koenig, S. Rothschild, M. Tamm, A. Hojski, D. Lardinois
Journal: Journal of Thoracic Oncology (2023)
EP08.02-13 Association of the Benefit of Durvalumab Consolidation Therapy and Driver Mutation Status for Locally Advanced Non-small Lung Cancer
Authors: Y. Akazawa, A. Yoshikawa, S. Miyamoto, K. Ameku, Y. Yano, M. Mori, J. Uchida
Journal: Journal of Thoracic Oncology (2023)
P2.21-05 CD47 as Biomarker of Prognosis in Patients with Malignant Pleural Mesothelioma
Authors: C.D. Izquierdo Tolosa, A. Aviles-Salas, L.A. Cabrera-Miranda, S. Samtani, A.L. Colín-González, H. González-Conchillos, N. Hernández-Pedro, W. Muñoz-Montaño, M. Orozco-Morales, B. Pineda, A.F. Cardona, O. Arrieta
Journal: Journal of Thoracic Oncology (2023)
EP08.02-04 Real-World Disease-Free Survival (DFS) in Non-metastatic Non-small Cell Lung Cancer (NSCLC): A German I-O Optimise Analysis
Authors: A. Waldmann, C. Leal, M.J. Schoemaker, N. Niklas, L. Labohm, H. Baltus, C. Rault, M.J. Daumont, G. Emanuel, M. Muwaffak, V. Saglimbene, S. Lucherini, L. Vo, A. Katalinic
Journal: Journal of Thoracic Oncology (2023)
EP08.02-32 Optimal Planning Target Volume Margins for Spirometer-Based DIBH Radiotherapy for Lung Cancer
Authors: N. Kishi, Y. Matsuo, T. Ono, N. Matsushita, N. Mukumoto, Y. Tsuruta, M. Sasaki, T. Fujimoto, M. Nakamura, T. Mizowaki
Journal: Journal of Thoracic Oncology (2023)
P2.06-04 First-Line Camrelizumab Plus Chemotherapy for Advanced Non-squamous NSCLC with Brain Metastases: Updated Data from CAP-BRAIN
Authors: x. hou, C. Zhou, G. Wu, W. Lin, Z. Xie, H. Zhang, J. Yi, Z. Peng, L. Yin, C. Ma, L. Chen
Journal: Journal of Thoracic Oncology (2023)
EP04.04-05 Ten-year CTNB Data Indicate Its Usefulness and Safety, Especially Salvage Situation after Bronchoscopy without Diagnosis
Authors: Y. Misumi, Y. Taniguchi, Y. Agemi, Y. Nakamura, T. Shimokawa, I. Torii, H. Okamoto
Journal: Journal of Thoracic Oncology (2023)
MA06.06 A Phase II Trial of Ceralasertib and Durvalumab in Advanced Non-Small Cell Lung Cancer (NSCLC) with and without RAS Mutations: Results of NLMT Arm J
Authors: G. Middleton, P. Fletcher, J. Savage, M. Mehmi, A. Greystoke, A. Dangoor, J. Cave, C. Escriu, P. Shaw, N. Steele, P. Jain, S. Popat, M. Forster, J. Spicer, N. Coupe, S. Danson, D. Gilligan, D. Muthukumar, G. Price, Y. Summers, E. Toy, L. Billingham
Journal: Journal of Thoracic Oncology (2023)
P1.20-06 Mapping the Histopathological Landscape of Lung Adenocarcinoma using Self-Supervised Learning Artificial Intelligence
Authors: A.C. Quiros, N. Coudray, A. Yeaton, X. Yang, B. Liu, L. Chiriboga, A. Karimkhan, N. Narula, D. Moore, C. Park, H. Pass, A. Moreira, J. Le Quesne, A. Tsirigos, K. Yuan
Journal: Journal of Thoracic Oncology (2023)
EP11.02-06 Atezolizumab vs Single-Agent Chemo in NSCLC Patients Ineligible for a 1L Platinum Regimen: Asian Subgroup Analysis of IPSOS
Authors: S.M. Lee, B. Han, S. Peters, A.T. Le, D. Huang, G. Wu, L. Cao, C.P. Pham, J. Zhao, K. Wang, N. Yang, H. Zhong, Y. Hu, S. Morris, V. Lam, V. Graupner, B. Gitlitz, E. Hoglander, C. Schulz
Journal: Journal of Thoracic Oncology (2023)
P2.05-10 The Power for PD-L1 Expression to Predict Immune Checkpoint Blockade Outcomes is Determined by Tumor Transcriptome
Authors: A. Li, L. Luo, W. Du, L. He, S. Fu, Y. Wang, Z. Yu, Y. Yang, W. Fang, L. Zhang, S. Hong
Journal: Journal of Thoracic Oncology (2023)
P1.18-02 Coordinating Lung Cancer Screening with Screening Mammography: The CALM Study
Authors: R.A. Smith, K.L. Sandler, E.A. Kazerooni, C. Jani, V. Welty, G. Paliotti, A. Ahmed, O. Al Omari, L. Agarwal, P. Bhatt, A. Rupal, M.M. Lotz, S. Pories, L. Khorashadi, A. Paulson, C. Godfrey, S. Joyner, H. Marmor, L. Hatcher, L. Fike, A. Gupta, S. Deppen, C.C. Thomson
Journal: Journal of Thoracic Oncology (2023)
P1.08-06 Impact of KRASG12D Subtype and Concurrent Pathogenic Mutations on Advanced Non-small Cell Lung Cancer Outcomes
Authors: E. Caballe, N. Hernandez-Pedro, M. Ramos-Ramirez, E. Romero-Nuñez, J. Lucio-Lozada, P. Barrios-Bernal, O. Arrieta
Journal: Journal of Thoracic Oncology (2023)
EP11.03-23 Efficacy of Nivolumab + Ipilimumab Vs other First-line Treatments for Metastatic NSCLC with PD-L1 &lt;1%: a Network Meta-analysis
Authors: K. O'Byrne, E. Popoff, F. Badin, A. Lee, Y. Yuan, S. Goring, L.J. Eccles, N. Varol, N. Waser, J.R. Penrod, G. Lozano-Ortega
Journal: Journal of Thoracic Oncology (2023)
P1.22-14 A Phase 3 Multicenter Study to Evaluate the Feasibility of a New NGS Panel Using Cytological Specimens for NSCLC
Authors: K. Morikawa, Y. Takashima, M. Oki, A. Tsuzuku, S. Murakami, D. Minami, S. Fujii, N. Shinagawa, F. Asano, S. Nakamura, Y. Sato, Y. Ueda, F. Suzuki, K. Tanabe, T. Yokose, M. Mineshita
Journal: Journal of Thoracic Oncology (2023)
P2.07-06 Real World Efficacy of First-Line Immunotherapy +/- Chemotherapy in Advanced NSCLC Stratified by Serum Proteomics
Authors: W. Akerley, H. Halawani, E. Schaefer, R. Page, B. Ghabach, J. Evans, L. Shunyakov, D. Oubre, A. Veatch, J. Akulian, V. Velcheti, T. Pitcher
Journal: Journal of Thoracic Oncology (2023)
P2.07-09 Stage 3 NSCLC Patients Progressing After Concurrent Chemo-Radiotherapy and Durvalumab- is There a Role for Another IO?
Authors: T. Shentzer Kutiel, M. Moskovitz, S. Shamai, B. Waissengrin, D. Urban, S. Daher, H. Sorotzky, M. Wollner, A. Zer, D. Reinhorn, O. Rotem, A. Alon, J. Bar
Journal: Journal of Thoracic Oncology (2023)
The emerging role of exosomes in communication between the periphery and the central nervous system
Authors: Wenxiu Han, Hailiang Zhang, Lei Feng, Ruili Dang, Jing Wang, Changmeng Cui, Pei Jiang
Journal: MedComm (2023)

Exosomes, membrane-enclosed vesicles, are secreted by all types of cells. Exosomes can transport various molecules, including proteins, lipids, functional mRNAs, and microRNAs, and can be circulated to various recipient cells, leading to the production of local paracrine or distal systemic effects. Numerous studies have proved that exosomes can pass through the blood-brain barrier, thus, enabling the transfer of peripheral substances into the central nervous system (CNS). Consequently, exosomes may be a vital factor in the exchange of information between the periphery and CNS. This review will discuss the structure, biogenesis, and functional characterization of exosomes and summarize the role of peripheral exosomes deriving from tissues like the lung, gut, skeletal muscle, and various stem cell types in communicating with the CNS and influencing the brain's function. Then, we further discuss the potential therapeutic effects of exosomes in brain diseases and the clinical opportunities and challenges. Gaining a clearer insight into the communication between the CNS and the external areas of the body will help us to ascertain the role of the peripheral elements in the maintenance of brain health and illness and will facilitate the design of minimally invasive techniques for diagnosing and treating brain diseases.
P1.26-08 Usefulness and Safety of Chest Tube Removal Regardless of Drainage Volume of Pleural Effusion in Patients Who Underwent Pulmonary Resection
Authors: T. Haruki, K. Takamochi, S. Oh, M. Endo, K. Funai, Y. Kitamura, M. Tsuboi, T. Tsukioka, H. Suzuki, H. Ito, N. Okumura, T. Ueno, N. Ikeda, H. Iwata, M. Okada, T. Ichikawa, T. Okamoto, S. Nojiri, K. Suzuki
Journal: Journal of Thoracic Oncology (2023)
P1.28-08 Definition of Resectable Stage III Non-Small Cell Lung Cancer: A Systematic Review from EORTC Lung Cancer Group
Authors: E. Xenophontos, N. Giaj Levra, V. Durieux, W. Van Geffen, G. Grisay, C. De la Pinta Alonso, H. Arasanz Esteban, E. Prisciandaro, R. Ferrara, J. Derks, J. Von der Thusen, C. Dickhoff, M. Brandao, C. Faivre-Finn, J. Edwards, D. De Ruysscher, J. Remon, A.-M. Dingemans, T. Berghmans
Journal: Journal of Thoracic Oncology (2023)
EP04.01-06 Double Blind Evaluation of Circulating Cancer Associated Macrophage Like (CAML) Cells for Detection of Cancer in Pulmonary Nodules
Authors: M. Edelman, A. Vachani, D. Hagan, E. Ross, R. Kumar, A. Haber, D. Dibardino, K. Ruth, J. Anaokar, M. Kumaran, C. Pagan, D. Adams, C.-M. Tang
Journal: Journal of Thoracic Oncology (2023)
EP12.01-34 Autopsy and Next Generation Sequencing Report of First-Line Treatment with Osimertinib for EGFR-Mutated Squamous Cell Carcinoma of the Lung
Authors: T. Nishimura, T. Fujiwara, H. Fujimoto, H. Ibata, E.C. Gabazza, T. Kobayashi
Journal: Journal of Thoracic Oncology (2023)
EP11.03-16 Re-immunotherapy with Nivolumab plus Ipilimumab in Advanced NSCLC Patients Previously Treated with Anti-PD-(L)1 Antibody
Authors: T. Imakita, K. Fujita, T. Ito, Z. Saito, I. Oi, O. Kanai, H. Tachibana, T. Mio
Journal: Journal of Thoracic Oncology (2023)
EP07.04-20 Identification of Tumor Microenvironment and Prognosis Risk Prediction through Proteomics Analysis in Stage I Lung Adenocarcinoma
Authors: None H-Y. chen, Y.-F. Lu, Y.-H. Chang, Y.-J. Chen, Y.-J. Chen, S.-L. Yu, J.-S. Chen
Journal: Journal of Thoracic Oncology (2023)
EP04.01-03 Advancing Malignancy Risk Stratification for Early-Stage Cancers in Lung Nodules by Combined Imaging and Electrical Impedance Analysis
Authors: D. Yang, C. Gu, Y. Gu, X. Zhang, D. Ge, Y. Zhang, N. Wang, X. Zheng, H. Wang, L. Yang, S. Chen, P. Xie, D. Chen, J. Yu, J. Sun, J.P. Pineda, C. Yuan, C. Chen, C. Hui, N. Zhou, C. Bai
Journal: Journal of Thoracic Oncology (2023)
EP07.01-07 Comparison of Surveillance with Contrast Chest CT and Non-contrast Chest CT among who Survived 2 Years after Curative Resection for Lung Cancer
Authors: B. Na, J.H. Park, T. Yun, K.J. Na, S. Park, I.K. Park, C.H. Kang, Y.T. Kim
Journal: Journal of Thoracic Oncology (2023)
P2.20-05 The Impact of Preoperative Immunotherapy On Peri-Operative Outcomes After Thymectomy for Thymic Epithelial Tumors
Authors: L.-Y. Wong, N. Kapula, D. Liou, N. Lui, M.F. Berry, J. Shrager, L. Backhus
Journal: Journal of Thoracic Oncology (2023)
EP07.05-07 Real-World Outcomes of Adjuvant Cisplatin/Vinorelbine vs Cisplatin/Pemetrexed in Resected Non-Squamous NSCLC
Authors: S.S.P. Low, C. Barrie, S. Campbell, K. MacLennan, I. Philips, M. MacKean
Journal: Journal of Thoracic Oncology (2023)
EP06.06-14 High Circulating Activin a Plasma Level Is Associated with Advanced Tumor Stage and Poor Prognosis in Lung Squamous Cell Cancer Patients
Authors: K. Sinn, A. Elbeialy, B. Mosleh, K. Hoetzenecker, V. Laszlo, B. Dome, M. Grusch, M.A. Hoda
Journal: Journal of Thoracic Oncology (2023)
EP07.01-29 What Is a Risk Factor for Postoperative Home Oxygen Therapy in Primary Lung Cancer Patients?
Authors: T. Yamanaka, Y. Sakairi, Y. Tada, H. Imabayashi, Y. Uematsu, D. Shimizu, T. Ochi, J. Yusa, H. Oeda, Y. Sata, T. Toyoda, T. Inage, K. Tanaka, H. Suzuki, Y. Matsui, I. Yoshino
Journal: Journal of Thoracic Oncology (2023)
EP11.03-25 A Novel Approach for Personalized Strategy of Cancer Immunotherapy with Pattern Identification: From the Results of the HARMONY Study
Authors: M-k. Jeong, J. Chun, J.-M. Yi, H. Jang, E. Cho, J. Choi, J.H. Lim, J. Son, S.H. Jang, S.H. Lee, J.G. Choi, I.-J. Oh, T.W. Jang, S.H. Yoon, S.J. Kim, C.M. Choi, S.Y. Lee
Journal: Journal of Thoracic Oncology (2023)
P2.29-01 Harnessing Artificial Intelligence to Expand Lung Cancer Clinical Trial Opportunities in Spain
Authors: M. Hardy Werbin, A.M. Degrave, S. González Gallardo, M. Szarfer Barenblit, L. Barenblit Mas, M. Sánchez Calleja, D. Lepke, A. Llopart Babot, J.J. García-Mosquera, E. Arriola Aperribay
Journal: Journal of Thoracic Oncology (2023)
P1.25-06 Real-world Primary Treatment Patterns in Stages I-III Non-Small Cell Lung Cancer
Authors: J.S. Donington, X. Hu, S. Zhang, C. Gao, A. Arunachalam, D. Chirovsky, A. Lerner, A. Jiang, J. Signorovitch, A. Samkari
Journal: Journal of Thoracic Oncology (2023)
EP06.02-05 Agreement among Programmed Cell Death Ligand-1 Immunohistochemistry Results Using 73-10, 22C3 and 28-8 Antibodies for Lung Cancer
Authors: T. Saito, M. Ishida, Y. Takeyasu, T. Utsumi, N. Maru, H. Matsui, Y. Taniguchi, H. Hino, T. Kurata, T. Murakawa
Journal: Journal of Thoracic Oncology (2023)
EP07.04-15 Diagnosis, Treatment Patterns and Outcomes in Patients with RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC) in China
Authors: S. Lu, L. Shen, Q. Wang, H. Chen, Y. Zhao, Y. Li, G. Segall, Y. Dyachkova, M. Khanal, X. Zhang, D. Ding, J. Shao, Q. Wang, Y. Gao, L. Pang
Journal: Journal of Thoracic Oncology (2023)
EP08.02-27 Trimodality Treatment of Superior Sulcus non-Small Cell Lung Cancer. An Institutional Series of 47 Consecutive Patients.
Authors: R. Dziedzic, R. Dziadziuszko, M. Lazar-Poniatowska, T. Marjanski, M. Lapinski, W. Rzyman
Journal: Journal of Thoracic Oncology (2023)
EP11.03-13 Real-World Efficacy of Atezolizumab in Patients with Previously Treated Advanced NSCLC in Spain - TRACKER Study
Authors: R. Álvarez, E. Carcereny, A. Padilla, J.M. Rodríguez García, J.F. Córdoba, E. Esteban, C. Aguado, J. Garde, A. Moreno Vega, C. Ávila Andrade, M. Sereno, A. Sánchez-Hernández, M. López-Brea, B. Massuti, C. Martí Blanco, M. Campayo, P. Arnáiz, D. Pérez Parente, C.A. Fajardo, I. Ramos
Journal: Journal of Thoracic Oncology (2023)
EP13.02-01 Minimally Invasive Surgery for Endobronchial Small Cell Lung Carcinoma following Neoadjuvant Chemotherapy
Authors: K. Konstantinidis, V. Ramfidis, K.M. Soultanis, C. Goga, K. Ploiarchopoulou, I. Lampaditis
Journal: Journal of Thoracic Oncology (2023)
EP12.01-76 Adding Amivantamab as a Salvage Strategy Post EGFR TKI (Osimertinib/Mobocertinib) in EGFRm+ NSCLC
Authors: None B.J. krayim, W. Kian, I.S. Granot, D. Kahala, N. Heching, N. Asna, A. Salhab, A. Krayim, L.C. Roisman, N. Peled
Journal: Journal of Thoracic Oncology (2023)
EP05.01-11 Lung Cancers Diagnosed in a Retrospective Cohort of Lung Nodule Patients in Singapore
Authors: M. Ruparel, C. Khoong, N. Lim, E. Lim, Y. Xu, C.K. Phua, W.-Y. Lim, J. Abisheganaden
Journal: Journal of Thoracic Oncology (2023)
P1.27-10 NEOIPOWER: Icotinib plus Chemotherapy as Neoadjuvant Treatment for Resectable Stage II-IIIB EGFR-mutant Lung Adenocarcinoma
Authors: F.-L. Lu, C. Lv, M.-L. Zhuo, X. Yang, S. Yan, J.-F. Chen, N. Wu
Journal: Journal of Thoracic Oncology (2023)
EP12.01-01 The Safety and Efficacy of Aumolertinib in Advanced NSCLC Patients with EGFRm Who were Intolerant to Osimertinib: A Retrospective Clinical Study
Authors: L. Sun, X. Huang, M. Zhong, J. Huang, Y. Cai, J. Huang, H. Liu, H. Qin, J. Li, B. Zhong, H. Zuo, G. Zhang, J. Yan, Z. Chen, Y. Chen, L. He, Y. Xiong, M. Xu, L. Pan, C. Xiong
Journal: Journal of Thoracic Oncology (2023)
P2.10-04 Real-World Outcome of Metastatic ALK-Positive Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors
Authors: C. Kamali, L. De Petris, K. Jatta, K. Viktorsson, R. Lewensohn, S. Ekman, P. Hydbring
Journal: Journal of Thoracic Oncology (2023)
P1.23-08 Clinical Utility of Combined Plasma and Tissue NGS in Patients with Advanced, Treatment-Naïve, Non-small Cell Lung Cancer
Authors: H. Bote de Cabo, M. Siringo, E. García-Lorenzo, A. Castelo, E. Conde, S. Hernández, F. López-Ríos Moreno, M. Herrera, J. Baena, Y. Ruano-Domínguez, A.B. Enguita, U. Pérez, L. Paz-Ares, J. Zugazagoitia
Journal: Journal of Thoracic Oncology (2023)
OA16.05 Assessing the Impact of Increasing Lung Screening Eligibility by Relaxing the Maximum Years since Quit Threshold. A Simulation Modeling Study
Authors: R. Meza, P. Cao, K. de Nijs, J. Jeon, R.A. Smith, K. ten Haaf, H. de Koning
Journal: Journal of Thoracic Oncology (2023)
P1.23-03 Amplicon-Based Liquid Biopsy Prospectively Detects More Tissue-Confirmed Guideline-Recommended Biomarkers in Lung Cancer
Authors: R. Dawar, J. Carney, J. Orsini, K. Scilla, G. Lopes, M.-H. Tan, Y.O. Tan, T.M. Chin, C.K. Toh, B.C. Goh, J. Samol
Journal: Journal of Thoracic Oncology (2023)
P1.26-05 Sublobar Resection is Equivalent to Lobectomy for Stage IA Adenocarcinoma Presenting as Subsolid Nodule
Authors: S. Harrison, R. Yip, D. Yankelevitz, A. Nasar, C. Spinelli, J. Port, R. Flores, B. Lee, N. Mynard, O. Chow, J. Villena-Vargas, C. Henschke, N. Altorki
Journal: Journal of Thoracic Oncology (2023)
P1.28-07 Dose-Response Relationship Between Radiotherapy and Loss in Lung Perfusion Determined From DECT and PET/CT in NSCLC
Authors: M. Gaudreault, N. Bucknell, B. Woon, T. Kron, M.S. Hofman, S. Siva, N. Hardcastle
Journal: Journal of Thoracic Oncology (2023)
EP07.04-19 Clinical and Molecular Profile and Risk Factors of Stage IA NSCLC Relapsing after Radical Resection
Authors: P. Bertoglio, F.T. Gallina, V. Aprile, F. Minervini, E. Melis, D. Bacchin, R. Tajè, M. Schnider, L. Valentini, E. Farinelli, E. Guerrini, P. Kestenholz, M. Lucchi, F. Facciolo, P. Solli
Journal: Journal of Thoracic Oncology (2023)
MA03.08 Regular Use of Pharmaceutical Opioids and Subsequent Risk of Lung Cancer
Authors: M. Sheikh, K. Alcala, D. Mariosa, X. Feng, P. Sarich, M. Weber, A. Fournier, P. Brennan, M.-O. Parat, S.-A. Pearson, H.A. Robbins
Journal: Journal of Thoracic Oncology (2023)
P2.07-02 Association between OS and Subsequent ICI in Control Arm Patients of First Line ICI-based RCTs of Advanced/Metastatic NSCLC: FDA Analysis
Authors: O. Akinboro, S. Chatterjee, P. Mishra-Kalyani, N. Drezner, E. Larkins, R. Pazdur, P. Kluetz, H. Singh
Journal: Journal of Thoracic Oncology (2023)
EP12.01-12 Comparing Different Anti-angiogenic Agents and TKI Combinations in EGFR-mutated Advanced NSCLC: a Retrospective Study
Authors: R.-L. Sun, Y.-T. Liao, C.-I. Shen, C.-L. Chiang, Y.-H. Tseng, T.-H. Hsiao, H.-S. Chao, Y.-H. Luo, Y.-M. Chen, H.-C. Huang
Journal: Journal of Thoracic Oncology (2023)
EP06.02-03 PD-L1 Expressions in Non-small Cell Lung Cancer and its Correlation with Imaging Findings
Authors: N. Shigeta, H. Adachi, H. Ito, T. Isaka, K. Murakami, J. Miura, N. Kikunishi, H. Saito, T. Yokose
Journal: Journal of Thoracic Oncology (2023)
EP06.05-08 Efficacy of Preoperative Biopsy in Predicting the Newly Proposed Histologic Grade of Resected Lung Adenocarcinoma
Authors: S. Ohtani, T. Taki, T. Miyoshi, K. Tane, J. Samejima, K. Aokage, M. Tsuboi, G. Ishii
Journal: Journal of Thoracic Oncology (2023)
OA18.05 Tumor Immune Microenvironment Profiling in Oligometastatic Non-Small Cell Lung Cancer with Brain Metastases
Authors: R.S. Werner, H. Moch, M. Weller, T. Weiss, L. Regli, E. Le Rhun, A. Curioni-Fontecedro, I. Opitz, A. Soltermann
Journal: Journal of Thoracic Oncology (2023)
EP07.04-12 Comparison of Pathologic Outcomes Following Neoadjuvant Regimens in Resectable Locally Advanced Non-Small Cell Lung Cancer
Authors: N. Wells, G.W. Peters, P.R. Soulos, B.D. Kavanagh, S. Lloyd, J.E. Meyer, B.A. Perez, H.S. Park
Journal: Journal of Thoracic Oncology (2023)
P2.12-05 Real-World Data of Biomarker Diagnostics, Treatment Strategy, and Survival Outcome with Advanced or Recurrent NSCLC in Japan
Authors: T. Tokito, T. Sakamoto, T. Matsubara, T. Takahama, T. Yokoyama, A. Nakamura, T. Okamoto, H. Akamatsu, M. Oki, Y. Sato, K. Tobino, K. Nishimura, M. Hiraoka, H. Kenmotsu, J. Fujimoto, M. Shimokawa, N. Yamamoto, K. Nakagawa
Journal: Journal of Thoracic Oncology (2023)
EP11.03-10 Similar Efficacy Observed for Frontline Immunotherapy in Ethnic-Minority Patients with Metastatic NSCLC
Authors: M. Lee, J. Liu, E. Miao, S. Wang, F. Zhang, J. Wei, J. Chung, X. Xue, B. Halmos, H.D. Hosgood, H. Cheng
Journal: Journal of Thoracic Oncology (2023)